Nuvation Bio Stock Forecast - Naive Prediction
| NUVB Stock | USD 6.15 0.14 2.33% |
The Naive Prediction forecasted value of Nuvation Bio on the next trading day is expected to be 5.33 with a mean absolute deviation of 0.44 and the sum of the absolute errors of 26.97. Nuvation Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Nuvation Bio stock prices and determine the direction of Nuvation Bio's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Nuvation Bio's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the RSI of Nuvation Bio's share price is approaching 41. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Nuvation Bio, making its price go up or down. Momentum 41
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.13) | EPS Estimate Current Year (0.45) | EPS Estimate Next Year 0.55 | Wall Street Target Price 11.6667 | EPS Estimate Current Quarter (0.15) |
Using Nuvation Bio hype-based prediction, you can estimate the value of Nuvation Bio from the perspective of Nuvation Bio response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Nuvation Bio using Nuvation Bio's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Nuvation using crowd psychology based on the activity and movement of Nuvation Bio's stock price.
Nuvation Bio Short Interest
A significant increase or decrease in Nuvation Bio's short interest from the previous month could be a good indicator of investor sentiment towards Nuvation. Short interest can provide insight into the potential direction of Nuvation Bio stock and how bullish or bearish investors feel about the market overall.
200 Day MA 3.9238 | Short Percent 0.1984 | Short Ratio 7.02 | Shares Short Prior Month 52.6 M | 50 Day MA 7.4938 |
Nuvation Bio Hype to Price Pattern
Investor biases related to Nuvation Bio's public news can be used to forecast risks associated with an investment in Nuvation. The trend in average sentiment can be used to explain how an investor holding Nuvation can time the market purely based on public headlines and social activities around Nuvation Bio. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Nuvation Bio Implied Volatility | 1.93 |
Nuvation Bio's implied volatility exposes the market's sentiment of Nuvation Bio stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Nuvation Bio's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Nuvation Bio stock will not fluctuate a lot when Nuvation Bio's options are near their expiration.
The Naive Prediction forecasted value of Nuvation Bio on the next trading day is expected to be 5.33 with a mean absolute deviation of 0.44 and the sum of the absolute errors of 26.97. Nuvation Bio after-hype prediction price | USD 6.15 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Nuvation Bio to cross-verify your projections. Prediction based on Rule 16 of the current Nuvation contract
Based on the Rule 16, the options market is currently suggesting that Nuvation Bio will have an average daily up or down price movement of about 0.12% per day over the life of the 2026-03-20 option contract. With Nuvation Bio trading at USD 6.15, that is roughly USD 0.007418 . If you think that the market is fully incorporating Nuvation Bio's daily price movement you should consider acquiring Nuvation Bio options at the current volatility level of 1.93%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Nuvation Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Nuvation Bio's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Nuvation Bio's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Nuvation Bio stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Nuvation Bio's open interest, investors have to compare it to Nuvation Bio's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Nuvation Bio is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Nuvation. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Nuvation Bio Additional Predictive Modules
Most predictive techniques to examine Nuvation price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Nuvation using various technical indicators. When you analyze Nuvation charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Nuvation Bio Cash Forecast
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Nuvation Bio's financial statements to predict how it will affect future prices.
Cash | First Reported 2019-03-31 | Previous Quarter 248 M | Current Value 98.9 M | Quarterly Volatility 161 M |
Nuvation Bio Naive Prediction Price Forecast For the 24th of January
Given 90 days horizon, the Naive Prediction forecasted value of Nuvation Bio on the next trading day is expected to be 5.33 with a mean absolute deviation of 0.44, mean absolute percentage error of 0.27, and the sum of the absolute errors of 26.97.Please note that although there have been many attempts to predict Nuvation Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Nuvation Bio's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Nuvation Bio Stock Forecast Pattern
| Backtest Nuvation Bio | Nuvation Bio Price Prediction | Buy or Sell Advice |
Nuvation Bio Forecasted Value
In the context of forecasting Nuvation Bio's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Nuvation Bio's downside and upside margins for the forecasting period are 0.06 and 13.13, respectively. We have considered Nuvation Bio's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Nuvation Bio stock data series using in forecasting. Note that when a statistical model is used to represent Nuvation Bio stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.8028 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.4422 |
| MAPE | Mean absolute percentage error | 0.067 |
| SAE | Sum of the absolute errors | 26.9716 |
Predictive Modules for Nuvation Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Nuvation Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nuvation Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Nuvation Bio After-Hype Price Prediction Density Analysis
As far as predicting the price of Nuvation Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Nuvation Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Nuvation Bio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Nuvation Bio Estimiated After-Hype Price Volatility
In the context of predicting Nuvation Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Nuvation Bio's historical news coverage. Nuvation Bio's after-hype downside and upside margins for the prediction period are 0.31 and 13.90, respectively. We have considered Nuvation Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Nuvation Bio is risky at this time. Analysis and calculation of next after-hype price of Nuvation Bio is based on 3 months time horizon.
Nuvation Bio Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Nuvation Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nuvation Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Nuvation Bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.59 | 7.81 | 0.09 | 0.04 | 9 Events / Month | 7 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
6.15 | 6.15 | 0.00 |
|
Nuvation Bio Hype Timeline
Nuvation Bio is now traded for 6.15. The entity has historical hype elasticity of -0.09, and average elasticity to hype of competition of 0.04. Nuvation is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is now at 0.59%. %. The volatility of related hype on Nuvation Bio is about 12596.77%, with the expected price after the next announcement by competition of 6.19. About 19.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.49. Nuvation Bio had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 9 days. Check out Historical Fundamental Analysis of Nuvation Bio to cross-verify your projections.Nuvation Bio Related Hype Analysis
Having access to credible news sources related to Nuvation Bio's direct competition is more important than ever and may enhance your ability to predict Nuvation Bio's future price movements. Getting to know how Nuvation Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Nuvation Bio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GPCR | Structure Therapeutics American | 0.03 | 12 per month | 2.83 | 0.17 | 8.96 | (5.94) | 110.34 | |
| EWTX | Edgewise Therapeutics | 0.03 | 3 per month | 4.02 | 0.17 | 14.33 | (5.57) | 38.85 | |
| JANX | Janux Therapeutics | (0.43) | 10 per month | 0.00 | (0.07) | 9.48 | (6.55) | 63.52 | |
| QURE | Uniqure NV | 0.03 | 6 per month | 0.00 | (0.14) | 9.37 | (10.75) | 60.67 | |
| VERA | Vera Therapeutics | 2.25 | 11 per month | 3.16 | 0.13 | 10.77 | (5.81) | 23.44 | |
| CLDX | Celldex Therapeutics | (0.82) | 7 per month | 2.91 | (0.02) | 6.44 | (5.22) | 13.96 | |
| VRDN | Viridian Therapeutics | (0.44) | 9 per month | 1.84 | 0.15 | 5.57 | (2.22) | 15.86 | |
| ABCL | Abcellera Biologics | 0.06 | 9 per month | 0.00 | (0.12) | 5.37 | (6.97) | 19.23 | |
| AUPH | Aurinia Pharmaceuticals | 0.17 | 29 per month | 1.86 | 0.11 | 4.73 | (3.46) | 14.95 | |
| OCUL | Ocular Therapeutix | (0.26) | 12 per month | 0.00 | (0.02) | 5.22 | (4.66) | 33.45 |
Other Forecasting Options for Nuvation Bio
For every potential investor in Nuvation, whether a beginner or expert, Nuvation Bio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Nuvation Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Nuvation. Basic forecasting techniques help filter out the noise by identifying Nuvation Bio's price trends.Nuvation Bio Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nuvation Bio stock to make a market-neutral strategy. Peer analysis of Nuvation Bio could also be used in its relative valuation, which is a method of valuing Nuvation Bio by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Nuvation Bio Market Strength Events
Market strength indicators help investors to evaluate how Nuvation Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nuvation Bio shares will generate the highest return on investment. By undertsting and applying Nuvation Bio stock market strength indicators, traders can identify Nuvation Bio entry and exit signals to maximize returns.
Nuvation Bio Risk Indicators
The analysis of Nuvation Bio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Nuvation Bio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting nuvation stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.49 | |||
| Semi Deviation | 4.44 | |||
| Standard Deviation | 7.85 | |||
| Variance | 61.55 | |||
| Downside Variance | 25.6 | |||
| Semi Variance | 19.73 | |||
| Expected Short fall | (5.33) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Nuvation Bio
The number of cover stories for Nuvation Bio depends on current market conditions and Nuvation Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Nuvation Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Nuvation Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Nuvation Bio Short Properties
Nuvation Bio's future price predictability will typically decrease when Nuvation Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Nuvation Bio often depends not only on the future outlook of the potential Nuvation Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nuvation Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 268.8 M | |
| Cash And Short Term Investments | 502.7 M |
Check out Historical Fundamental Analysis of Nuvation Bio to cross-verify your projections. For information on how to trade Nuvation Stock refer to our How to Trade Nuvation Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvation Bio. If investors know Nuvation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.49) | Revenue Per Share | Quarterly Revenue Growth 17.047 | Return On Assets | Return On Equity |
The market value of Nuvation Bio is measured differently than its book value, which is the value of Nuvation that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvation Bio's value that differs from its market value or its book value, called intrinsic value, which is Nuvation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvation Bio's market value can be influenced by many factors that don't directly affect Nuvation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.